PetVivo Holdings, Inc. PETV

PETV Company Overview

PetVivo Holdings, Inc. is a U.S.-based biomedical and medical device company focused on the development, commercialization, and licensing of veterinary therapeutics for companion animals and horses. The company operates primarily within the veterinary health, regenerative medicine, and animal therapeutics industries, with a commercial emphasis on osteoarthritis and joint-related conditions in animals. Its principal revenue driver is the sale of its lead veterinary medical device product, SPRYNG with OsteoCushion Technology, an intra-articular injectable intended for the management of lameness and joint dysfunction in dogs and horses. The company also maintains a pipeline of biomaterials and veterinary therapeutic technologies aimed at addressing musculoskeletal disorders.

PetVivo was founded in 2009 and evolved from a research-oriented regenerative medicine company into a commercial-stage veterinary device business. The company’s strategy has centered on adapting biomaterials and tissue engineering technologies originally developed for human medicine into veterinary applications. Public filings and investor disclosures indicate that PetVivo positions itself through a combination of proprietary biomaterial science, veterinary-focused commercialization, and a niche emphasis on non-surgical treatment alternatives for osteoarthritis in companion animals and equine markets.